Correlation Between SNDL and Crispr Therapeutics
Can any of the company-specific risk be diversified away by investing in both SNDL and Crispr Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SNDL and Crispr Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SNDL Inc and Crispr Therapeutics AG, you can compare the effects of market volatilities on SNDL and Crispr Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SNDL with a short position of Crispr Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of SNDL and Crispr Therapeutics.
Diversification Opportunities for SNDL and Crispr Therapeutics
-0.84 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between SNDL and Crispr is -0.84. Overlapping area represents the amount of risk that can be diversified away by holding SNDL Inc and Crispr Therapeutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Crispr Therapeutics and SNDL is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SNDL Inc are associated (or correlated) with Crispr Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Crispr Therapeutics has no effect on the direction of SNDL i.e., SNDL and Crispr Therapeutics go up and down completely randomly.
Pair Corralation between SNDL and Crispr Therapeutics
Given the investment horizon of 90 days SNDL Inc is expected to generate 2.51 times more return on investment than Crispr Therapeutics. However, SNDL is 2.51 times more volatile than Crispr Therapeutics AG. It trades about 0.17 of its potential returns per unit of risk. Crispr Therapeutics AG is currently generating about -0.19 per unit of risk. If you would invest 136.00 in SNDL Inc on February 19, 2024 and sell it today you would earn a total of 110.00 from holding SNDL Inc or generate 80.88% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
SNDL Inc vs. Crispr Therapeutics AG
Performance |
Timeline |
SNDL Inc |
Crispr Therapeutics |
SNDL and Crispr Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with SNDL and Crispr Therapeutics
The main advantage of trading using opposite SNDL and Crispr Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SNDL position performs unexpectedly, Crispr Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Crispr Therapeutics will offset losses from the drop in Crispr Therapeutics' long position.The idea behind SNDL Inc and Crispr Therapeutics AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.Crispr Therapeutics vs. Pfizer Inc | Crispr Therapeutics vs. Nayax | Crispr Therapeutics vs. HP Inc | Crispr Therapeutics vs. GCM Grosvenor |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Complementary Tools
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
CEOs Directory Screen CEOs from public companies around the world | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |